CHEMORADIOTHERAPY

This study is testing whether adding two newer drugs, toripalimab and surufatinib, to the standard treatment of chemotherapy and radiation can better control a fast-growing type of lung cancer. It will involve about 47 adults with limited-stage small cell lung cancer. The goal is…

This study is testing a new combination of drugs and radiation to control advanced esophageal cancer that cannot be removed by surgery. It will involve 69 adults who have not had prior cancer treatment. The goal is to see if adding a drug called surufatinib to standard chemo-immu…

This study is testing a new combination of treatments for people with locally advanced rectal cancer. The goal is to see if adding an immunotherapy drug to a standard mix of radiation, chemotherapy, and a targeted drug can better shrink tumors before surgery. Researchers will com…

This study is testing if a drug called mecapegfilgrastim can safely prevent a serious side effect of combined chemotherapy and radiation for chest cancers. The side effect, called myelosuppression, causes dangerously low white blood cell counts, increasing infection risk. Researc…

This study aims to check how closely hospitals across India follow national guidelines for treating cervical cancer with radiation and chemotherapy. It will observe about 618 patients' treatment records to see if care matches the standards. The goal is to identify where treatment…